Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder (TACGAD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Sumitomo Pharmaceutical (Suzhou) Co., Ltd.
Sponsor:
Information provided by (Responsible Party):
Sumitomo Pharmaceutical (Suzhou) Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01614041
First received: November 11, 2011
Last updated: November 19, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2017
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)